Cardiology Advisor Institute Spotlight Course

Mitral Valve Disease: Role of Transcatheter Intervention for Optimal Lifetime Management

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s)

1.00 CME CE: Join three top experts in the field as they discuss the state-of-the-art in mitral valve repair and replacement. Exp 1/13/24

Additional Cardiology Courses

An Individualized Approach to PAH Therapy Based on Clinical Data, Goal-Directed Therapy, and Risk Stratification

AMA PRA Category 1 Credit(s)^TM

1.00 CME: Pulmonary arterial hypertension requires risk stratification to develop goal-directed treatment plans, including combination therapy targeting multiple pathways. Exp 12/27/23

Cardiac Risk Stratification in Action

AMA PRA Category 1 Credit(s)^TM

In the third part of this CME series, faculty will discuss patient cases to assess hs-cTn testing as a prognostic tool for secondary and primary prevention.

Mineralocorticoid Receptor Antagonists: Addressing Residual Risk in Patients with Cardiac Disease, T2DM, and CKD

AMA PRA Category 1 Credit(s)^TM, ABIM MOC Points

1.00 CME: Provides cardiologists information about the interrelationship of CVD and renal disease and the efficacy and safety of MRAs as well as expert guidance about the role of MRAs in the management of patients with T2DM, CKD, and CVD. Exp 12/20/23

Cardiology: Real-World Tactics to Address Health Inequities

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists, AAPA Category 1 CME Credit, ABIM MOC Points

0.75 CME CE: In this activity, an expert faculty follows the journey of a 48-yr. old Black female with AF to illuminate disparities in the quality of care she is offered. Exp 2/17/24

Pathways for Optimal Sequencing, Rapid Initiation, and Titration of Therapy in Patients with Heart Failure

AMA PRA Category 1 Credit(s)^TM

1.50 CME: Find out why the treatment landscape of pulmonary arterial hypertension (PAH) is poised to change dramatically in the near future. Exp 7/14/24

High-Sensitivity Cardiac Troponin-I in Cardiac Risk Stratification: Expert Opinion

AMA PRA Category 1 Credit(s)^TM

In the second part of this CME series, faculty will evaluate evolving applications of high-sensitivity cardiac troponin testing in CVD primary prevention.

Decision Points in Heart Failure: Let’s Meet Our Next Patient

AMA PRA Category 1 Credit(s)^TM, AANP Contact Hour(s)

0.50 CME CE: In this case-based activity, learners will practice incorporating recent data and guideline updates into realistic clinical scenarios of patients with HF. Exp 6/29/24

Mitral Valve Disease: Role of Transcatheter Intervention for Optimal Lifetime Management

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s)

1.00 CME CE: Join three top experts in the field as they discuss the state-of-the-art in mitral valve repair and replacement. Exp 1/13/24

The Past, Present, and Future of Intravenous Platelet Inhibition in the Catheterization Laboratory

AMA PRA Category 1 Credit(s)^TM, ABIM MOC Points

1.00 CME: Learn the latest in IV platelet inhibition by reviewing the CHAMPION trials and applying the latest research with a case on heavy thrombus burden. Exp 2/23/24

Multidisciplinary Strategies to Prevent Hospitalization in Patients with Worsening Heart Failure

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists

1.00 CME CE: Interactive format allows the multidisciplinary team to positively impact outcomes for patients experiencing worsening HF and hospitalizations. Exp 8/18/24

Aortic Stenosis: Delivering the Best Care Today and Tomorrow

AMA PRA Category 1 Credit(s)^TM, ABIM MOC Points

1.00 CME: Identify strategies for treating aortic stenosis in the elderly for improved outcomes. Discuss TAVR repeatability and coronary access for valve-in-valve TAVR. Exp 2/23/24

Risk Stratification and Prevention of Cardiovascular Disease

AMA PRA Category 1 Credit(s)^TM

High-sensitivity cardiac troponin (hs-cTn) testing and its emerging role in secondary and primary prevention in cardiovascular disease (CVD).